PCRX Stock-Based Compensation
$55.97MTTM · USD
Period ending:
PCRX FY Stock-Based CompUSD
$57.50M$0.00
2008-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
PCRX stock-based compensation history
Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 57,502,000 | |
| 51,171,000 | |
| 47,895,000 | |
| 48,092,000 | |
| 42,246,000 | |
| 39,920,000 | |
| 33,650,000 | |
| 31,725,000 | |
| 31,601,000 | |
| 31,248,000 | |
| 33,368,000 | |
| 24,822,000 | |
| 11,513,000 | |
| 4,776,000 | |
| 2,493,000 | |
| 23,000 | |
| 524,000 | |
| 242,000 |
Compare stock-based compensation
All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics
